Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index.

Hughes LE, Bonell S, Natt RS, Wilson C, Tiwana H, Ebringer A, Cunningham P, Chamoun V, Thompson EJ, Croker J, Vowles J.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1181-8.

2.

Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis.

Hughes LE, Smith PA, Bonell S, Natt RS, Wilson C, Rashid T, Amor S, Thompson EJ, Croker J, Ebringer A.

J Neuroimmunol. 2003 Nov;144(1-2):105-15.

PMID:
14597104
3.

No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis.

Chapman MD, Hughes LE, Wilson CD, Namnyak S, Thompson EJ, Giovannoni G.

Eur Neurol. 2005;53(1):27-31. Epub 2005 Feb 1.

PMID:
15687729
4.

Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker.

Ebringer A, Hughes L, Rashid T, Wilson C.

Arch Neurol. 2005 Jan;62(1):33-6. Review.

PMID:
15642847
5.

A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.

Yamashita M, Hida Y, Sugimoto H, Takahashi N, Kimura H, Nakatomi Y, Yoshida H, Ishizaki T.

J Microbiol Methods. 2010 Sep;82(3):198-204. doi: 10.1016/j.mimet.2010.06.002. Epub 2010 Jun 9.

PMID:
20538018
6.

The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.

Ebringer A, Rashid T, Wilson C.

Med Hypotheses. 2012 Jun;78(6):763-9. doi: 10.1016/j.mehy.2012.02.026. Epub 2012 Apr 5.

7.
8.
9.

Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.

Matthews RC, Burnie JP, Tabaqchali S.

J Clin Pathol. 1986 Dec;39(12):1306-12.

10.
11.
12.

Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa.

Peleg AY, Tilahun Y, Fiandaca MJ, D'Agata EM, Venkataraman L, Moellering RC Jr, Eliopoulos GM.

J Clin Microbiol. 2009 Mar;47(3):830-2. doi: 10.1128/JCM.01724-08. Epub 2008 Dec 30.

13.

Antibodies against light neurofilaments in multiple sclerosis patients.

Bartos A, Fialová L, Soukupová J, Kukal J, Malbohan I, Pitha J.

Acta Neurol Scand. 2007 Aug;116(2):100-7.

PMID:
17661795
14.

[Neurofilament protein light in multiple sclerosis].

Zhang Y, Li X, Qiao J.

Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2745-9. Chinese.

PMID:
18167263
15.
16.
17.

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T.

Brain. 1999 Nov;122 ( Pt 11):2047-56.

PMID:
10545390
18.
19.

Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.

Giordano A, Magni A, Filadoro F, Graziani C, Quattrucci S, Cipriani P.

New Microbiol. 1998 Oct;21(4):375-8.

PMID:
9812319
20.

Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.

Jensen P, Johansen HK, Lanng S, Høiby N.

Pediatr Res. 2001 Mar;49(3):423-8.

PMID:
11228271

Supplemental Content

Support Center